WILSON SONS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.41 BRL | -1.56% |
|
-4.04% | -6.01% |
| 08/05 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
| 08/05 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 727.4 | 897.6 | 1,583 | 1,401 | - | - |
| Enterprise Value (EV) 1 | 1,190 | 1,370 | 1,583 | 1,885 | 1,864 | 1,401 |
| P/E ratio | 16.8 x | 14.4 x | 19.9 x | 20.1 x | 17.9 x | - |
| Yield | 5.53% | - | - | 2.48% | 2.8% | - |
| Capitalization / Revenue | 1.84 x | 2.08 x | 3.25 x | 2.98 x | 2.57 x | 2.3 x |
| EV / Revenue | 3 x | 3.18 x | 3.25 x | 4.01 x | 3.42 x | 2.3 x |
| EV / EBITDA | 6.73 x | 7.83 x | 7.92 x | 9.43 x | 8.04 x | 5.39 x |
| EV / FCF | - | - | - | 15.7 x | 11.6 x | 7.2 x |
| FCF Yield | - | - | - | 6.39% | 8.63% | 13.9% |
| Price to Book | 1.5 x | 1.98 x | - | 2.68 x | 2.49 x | - |
| Nbr of stocks (in thousands) | 4,37,160 | 4,39,341 | 4,39,989 | 4,39,989 | - | - |
| Reference price 2 | 1.664 | 2.043 | 3.599 | 3.183 | 3.183 | 3.183 |
| Announcement Date | 23/03/22 | 23/03/23 | 21/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 406.1 | - | 396.4 | 431.1 | 487.8 | 470.6 | 545.2 | 609.5 |
| EBITDA 1 | 118.1 | - | 176.9 | 174.9 | 200 | 199.9 | 231.8 | 260 |
| EBIT 1 | 87.88 | 80.28 | 97.97 | 115 | 134.4 | 136.9 | 156.7 | 181.6 |
| Operating Margin | 21.64% | - | 24.72% | 26.68% | 27.56% | 29.09% | 28.74% | 29.79% |
| Earnings before Tax (EBT) 1 | - | - | 69.6 | 90.2 | 109.1 | 105.3 | 118.2 | - |
| Net income 1 | - | 19.49 | 40.07 | 64.3 | 81.38 | 69.55 | 78.04 | - |
| Net margin | - | - | 10.11% | 14.92% | 16.68% | 14.78% | 14.31% | - |
| EPS 2 | - | 0.0439 | 0.0992 | 0.1419 | 0.1808 | 0.1580 | 0.1780 | - |
| Free Cash Flow 1 | - | 56.13 | - | - | - | 120.4 | 160.9 | 194.6 |
| FCF margin | - | - | - | - | - | 25.59% | 29.5% | 31.92% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 60.24% | 69.4% | 74.83% |
| FCF Conversion (Net income) | - | 287.99% | - | - | - | 173.18% | 206.11% | - |
| Dividend per Share 2 | - | - | 0.0921 | - | - | 0.0790 | 0.0890 | - |
| Announcement Date | 12/03/20 | 12/03/21 | 23/03/22 | 23/03/23 | 21/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 119 | 104.3 | 106.8 | 120.1 | 110.8 | 114.9 | 121 | 127.2 | 129.6 | 126.6 |
| EBITDA 1 | 39.05 | 47.13 | 39.82 | 48.13 | 42.5 | 45.83 | 48.72 | 55.19 | 52.33 | 55.05 |
| EBIT | - | - | - | - | - | - | - | 37.13 | - | - |
| Operating Margin | - | - | - | - | - | - | - | 29.19% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
| Net income | - | 28.29 | - | - | - | 17.19 | 22.7 | 19.49 | 22.75 | - |
| Net margin | - | 27.12% | - | - | - | 14.96% | 18.75% | 15.32% | 17.55% | - |
| EPS | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 23/03/22 | 13/05/22 | 10/08/22 | 09/11/22 | 23/03/23 | 10/05/23 | 09/08/23 | 14/11/23 | 21/03/24 | 07/05/24 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 451 | - | 463 | 472 | - | 484 | 464 | - |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.822 x | - | 2.615 x | 2.7 x | - | 2.423 x | 2 x | - |
| Free Cash Flow 1 | - | 56.1 | - | - | - | 120 | 161 | 195 |
| ROE (net income / shareholders' equity) | 6.02% | 4.21% | 10.3% | 14.4% | - | 13.8% | 14.4% | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 1.110 | 1.030 | - | 1.190 | 1.280 | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | 85.7 | - | - | - | - | - | - | - |
| Capex / Sales | 21.1% | - | - | - | - | - | - | - |
| Announcement Date | 12/03/20 | 12/03/21 | 23/03/22 | 23/03/23 | 21/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
3.183
USD
Average target price
3.474
USD
Spread / Average Target
+9.15%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.01% | 1.42B | |
| +43.44% | 12.56B | |
| +20.74% | 6.4B | |
| +10.12% | 2B | |
| -14.29% | 1.97B | |
| +12.17% | 1.85B | |
| +29.76% | 1.15B | |
| +19.57% | 1.03B | |
| -.--% | 971M | |
| +36.67% | 715M |
- Stock Market
- Equities
- PORT3 Stock
- Financials Wilson Sons S.A.